+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Multiomics Market by Product (Consumables, Instrument, Software), Type (Epigenomics, Genomics, Metabolomics), Application, End-User - Forecast 2024-2030- Product Image
Global Multiomics Market by Product (Consumables, Instrument, Software), Type (Epigenomics, Genomics, Metabolomics), Application, End-User - Forecast 2024-2030- Product Image
Sale

Global Multiomics Market by Product (Consumables, Instrument, Software), Type (Epigenomics, Genomics, Metabolomics), Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 198 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5889740
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Multiomics Market size was estimated at USD 83.55 billion in 2023, USD 96.86 billion in 2024, and is expected to grow at a CAGR of 16.26% to reach USD 239.92 billion by 2030.

Multiomics integrates various types of biological data, including several omics, such as genomics, transcriptomics, and metabolomics, to comprehensively understand cellular functions, disease mechanisms, and potential therapeutic targets. Multiomics explains complex biological systems by studying the interaction and function between the different molecular compounds. Growing advancements in omics technologies such as next-generation sequencing (NGS), mass spectrometry-based proteomics, high-throughput gene expression profiling platforms, and bioinformatics tools for data integration is expanding the usage of multiomics. Additionally, the increased adoption of personalized medicine, which relies on a deep understanding of individual genetic makeup and response to various drugs, is expanding the scope of multiomics discipline. Furthermore, growing investments in research & development (R&D) activities from the public and private sectors to discover new biomarkers drive market growth. The high cost of handling massive datasets generated from different omics platforms, which often require high-performance computing infrastructure and advanced bioinformatics tools for accurate interpretation, is hampering the market growth. The increasing integration of ML and AI algorithms into multiomics data analysis, which revolutionizes drug discovery processes by identifying novel targets and predicting patient responses, is expected to bolster the growth of the multiomics market.

Regional Insights

The availability of well-established healthcare infrastructure and advanced regulatory frameworks that support research and development activities across the U.S., Canada, and Brazil is expanding the scope of the multiomics in the Americas. Pharmaceutical companies in the region are increasingly collaborating with research institutions to develop innovative solutions for precision medicine using multiomics technologies, thereby benefiting the multiomics market in the Americas. Increasing investments in biotechnology research, growing awareness about personalized medicine among patients, and favorable government initiatives to promote healthcare advancements are creating a platform for the multiomics market in Asia-Pacific. In the EMEA region, expanding advanced medical infrastructure and a growing focus on precision medicine research are expanding market growth. The European Union has implemented the General Data Protection Regulation (GDPR) that affects data handling and storage for multiomics studies, making it essential for manufacturers to comply with these regulations.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Multiomics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Multiomics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Multiomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., AstraZeneca PLC, Becton, Dickinson and Company, Berkeley Lights, Inc., BGI Genomics Co. Ltd, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioLegend, Inc. by PerkinElmer, Inc., Celsee, Charles River Laboratories International, Inc., Danaher Corporation, Dolomite Bio by Unchained Labs, EpiCypher, Inc., Google LLC by Alphabet Inc., Illumina, Inc., Miltenyi Biotec, Mission Bio, Inc., Multiomic Health Limited, NanoCellect Biomedical, NanoString Technologies, Inc., Novo Nordisk A/S, Olink Proteomics AB, QIAGEN N.V., Shimadzu Corporation, Singleron Biotechnologies GmbH, Standard BioTools Inc., TAKARA BIO INC., Tempus Labs, Inc., and Thermo Fischer Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Multiomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
    • Instrument
    • Software
  • Type
    • Epigenomics
    • Genomics
    • Metabolomics
    • Microbiomics
    • Proteomics
    • Transcriptomics
  • Application
    • Agriculture & Plant Science
    • Diagnostics
    • Drug Discovery
    • Precision Medicine
  • End-User
    • Academic & Research Institutes
    • Biotechnology Companies
      • Agriculture
      • Environmental Science
      • Forensics
      • Plant & Animal Breeding
    • Hospitals & Clinics
    • Pharmaceutical & Biopharmaceutical Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Multiomics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Multiomics Market?
  3. What are the technology trends and regulatory frameworks in the Multiomics Market?
  4. What is the market share of the leading vendors in the Multiomics Market?
  5. Which modes and strategic moves are suitable for entering the Multiomics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Multiomics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing advancements in NGS, mass spectrometry-based proteomics, and gene expression profiling platforms
5.1.1.2. High potential owing to a growing preference towards personalized medicines
5.1.1.3. Rising research & development activities conducted by biotechnology companies
5.1.2. Restraints
5.1.2.1. High cost and limited skilled professionals associated with multiomics
5.1.3. Opportunities
5.1.3.1. Growing integration of advanced technologies into multiomics
5.1.3.2. Increasing investments in agriculture research and environmental science with sustainability targets
5.1.4. Challenges
5.1.4.1. Limited standard protocols for data acquisition, storage, and sharing across omics studies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Multiomics Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Instrument
6.4. Software
7. Multiomics Market, by Type
7.1. Introduction
7.2. Epigenomics
7.3. Genomics
7.4. Metabolomics
7.5. Microbiomics
7.6. Proteomics
7.7. Transcriptomics
8. Multiomics Market, by Application
8.1. Introduction
8.2. Agriculture & Plant Science
8.3. Diagnostics
8.4. Drug Discovery
8.5. Precision Medicine
9. Multiomics Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Biotechnology Companies
9.4.1. Agriculture
9.4.2. Environmental Science
9.4.3. Forensics
9.4.4. Plant & Animal Breeding
9.4. Hospitals & Clinics
9.5. Pharmaceutical & Biopharmaceutical Companies
10. Americas Multiomics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Multiomics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Multiomics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Agreement, Collaboration, & Partnership
13.3.1.1. Tempus Announces New Multi-omics Collaboration with Actuate Therapeutics
13.3.2. New Product Launch & Enhancement
13.3.2.1. Biomodal Launches New Multiomics Sequencing Technology
13.3.2.2. BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery
13.3.3. Investment & Funding
13.3.3.1. MultiOmic Health Closes USD 6.2 Million Funding Round to Discover Precision Medicines for Metabolic Syndrome-Related Conditions
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. 10x Genomics, Inc.
14.1.2. AstraZeneca PLC
14.1.3. Becton, Dickinson and Company
14.1.4. Berkeley Lights, Inc.
14.1.5. BGI Genomics Co. Ltd
14.1.6. Bio-Rad Laboratories, Inc.
14.1.7. Bio-Techne Corporation
14.1.8. BioLegend, Inc. by PerkinElmer, Inc.
14.1.9. Celsee
14.1.10. Charles River Laboratories International, Inc.
14.1.11. Danaher Corporation
14.1.12. Dolomite Bio by Unchained Labs
14.1.13. EpiCypher, Inc.
14.1.14. Google LLC by Alphabet Inc.
14.1.15. Illumina, Inc.
14.1.16. Miltenyi Biotec
14.1.17. Mission Bio, Inc.
14.1.18. Multiomic Health Limited
14.1.19. NanoCellect Biomedical
14.1.20. NanoString Technologies, Inc.
14.1.21. Novo Nordisk A/S
14.1.22. Olink Proteomics AB
14.1.23. QIAGEN N.V.
14.1.24. Shimadzu Corporation
14.1.25. Singleron Biotechnologies GmbH
14.1.26. Standard BioTools Inc.
14.1.27. TAKARA BIO INC.
14.1.28. Tempus Labs, Inc.
14.1.29. Thermo Fischer Scientific Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. MULTIOMICS MARKET RESEARCH PROCESS
FIGURE 2. MULTIOMICS MARKET SIZE, 2023 VS 2030
FIGURE 3. MULTIOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MULTIOMICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. MULTIOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MULTIOMICS MARKET DYNAMICS
FIGURE 7. MULTIOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. MULTIOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. MULTIOMICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. MULTIOMICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. MULTIOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. MULTIOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. MULTIOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. MULTIOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MULTIOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES MULTIOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. MULTIOMICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. MULTIOMICS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. MULTIOMICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. MULTIOMICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MULTIOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MULTIOMICS MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MULTIOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 10. MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. MULTIOMICS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. MULTIOMICS MARKET SIZE, BY MICROBIOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. MULTIOMICS MARKET SIZE, BY AGRICULTURE & PLANT SCIENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. MULTIOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. MULTIOMICS MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. MULTIOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 25. MULTIOMICS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. MULTIOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. MULTIOMICS MARKET SIZE, BY FORENSICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. MULTIOMICS MARKET SIZE, BY PLANT & ANIMAL BREEDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. MULTIOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 47. CANADA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. CANADA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. CANADA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. CANADA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. CANADA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 52. MEXICO MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. MEXICO MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. MEXICO MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MEXICO MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. MEXICO MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES MULTIOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 74. CHINA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. CHINA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. CHINA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. CHINA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. CHINA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 79. INDIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. INDIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. INDIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. INDIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. INDIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 89. JAPAN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. JAPAN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. JAPAN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. JAPAN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. JAPAN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. MALAYSIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. PHILIPPINES MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. SINGAPORE MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. SOUTH KOREA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. TAIWAN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 119. THAILAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. THAILAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. THAILAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. THAILAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. THAILAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. VIETNAM MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. DENMARK MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. DENMARK MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. DENMARK MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. DENMARK MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. DENMARK MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 140. EGYPT MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. EGYPT MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. EGYPT MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. EGYPT MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. EGYPT MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 145. FINLAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. FINLAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. FINLAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. FINLAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. FINLAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 150. FRANCE MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. FRANCE MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. FRANCE MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. FRANCE MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. FRANCE MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 155. GERMANY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. GERMANY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. GERMANY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. GERMANY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. GERMANY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. ISRAEL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 165. ITALY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. ITALY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. ITALY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. ITALY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. ITALY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. NIGERIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 180. NORWAY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. NORWAY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. NORWAY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. NORWAY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. NORWAY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 185. POLAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. POLAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 187. POLAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. POLAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. POLAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 190. QATAR MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. QATAR MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 192. QATAR MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. QATAR MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. QATAR MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 210. SPAIN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. SPAIN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 212. SPAIN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SPAIN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. SPAIN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. SWEDEN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 225. TURKEY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. TURKEY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 227. TURKEY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. TURKEY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. TURKEY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 240. MULTIOMICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 241. MULTIOMICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 242. MULTIOMICS MARKET LICENSE & PRICING

Companies Mentioned

  • 10x Genomics, Inc.
  • AstraZeneca PLC
  • Becton, Dickinson and Company
  • Berkeley Lights, Inc.
  • BGI Genomics Co. Ltd
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioLegend, Inc. by PerkinElmer, Inc.
  • Celsee
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Dolomite Bio by Unchained Labs
  • EpiCypher, Inc.
  • Google LLC by Alphabet Inc.
  • Illumina, Inc.
  • Miltenyi Biotec
  • Mission Bio, Inc.
  • Multiomic Health Limited
  • NanoCellect Biomedical
  • NanoString Technologies, Inc.
  • Novo Nordisk A/S
  • Olink Proteomics AB
  • QIAGEN N.V.
  • Shimadzu Corporation
  • Singleron Biotechnologies GmbH
  • Standard BioTools Inc.
  • TAKARA BIO INC.
  • Tempus Labs, Inc.
  • Thermo Fischer Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages198
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 96.86 Billion
Forecasted Market Value ( USD ) by 2030 $ 239.92 Billion
Compound Annual Growth Rate16.2%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Global Metabolomics Market by Product & Service (Bioinformatics Tools & Services, Metabolomics Instruments), Indication (Cancer, Cardiovascular Disorders, Inborn Errors of Metabolism), Application, End User - Forecast 2024-2030 - Product Image

Global Metabolomics Market by Product & Service (Bioinformatics Tools & Services, Metabolomics Instruments), Indication (Cancer, Cardiovascular Disorders, Inborn Errors of Metabolism), Application, End User - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From
Metabolomics: Global Strategic Business Report - Product Image

Metabolomics: Global Strategic Business Report

  • Report
  • 268 Pages
  • Global
From
Metabolomics Global Market Report 2024 - Product Image

Metabolomics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Metabolomics Market - Global Outlook & Forecast 2023-2028 - Product Image

Metabolomics Market - Global Outlook & Forecast 2023-2028

  • Report
  • 305 Pages
  • Global
From
Global Metabolomics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Global Metabolomics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 116 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.